Pfizer’s Dividend Freeze Raises a Bigger Question About Its Cash Flow

Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash generation. The math behind that payout is more uncomfortable than the headline numbers suggest.